After so much hype, it turns out vaccine manufacturer Novavax’s long-awaited COVID jab hit the market far too late. In its second quarter earnings on Monday,...
Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. Read More
The news: Two new sets of vaccine results announced today suggest the South African variant of the virus is proving harder to vaccinate against. Novavax and...